<DOC>
	<DOCNO>NCT00309218</DOCNO>
	<brief_summary>The present study investigate safety efficacy steroid withdrawal pediatric renal transplant recipient stable graft function concomitant immunosuppression cyclosporine mycophenolate mofetil .</brief_summary>
	<brief_title>Steroid Withdrawal Pediatric Renal Transplant Recipients Under Cyclosporine ( CyA ) Mycophenolate Mofetil ( MMF )</brief_title>
	<detailed_description>The present protocol aim investigate steroid-saving potential MMF pediatric patient NTx . Over 2-year period , two treatment regime compare randomized form patient stable renal transplant function course 12 - 24 month transplantation ( control first study phase ) : Branch A : CyA + MMF + withdrawal steroid three-month period follow randomization Branch B : CyA + MMF + 4 mg/m² methylprednisolone ( prednisolone equivalent ) /day After two year observation , steroid control group ( branch B ) withdrawn optionally conformity protocol branch A ( uncontrolled second study phase ) . It expect part patient decide favour withdrawal steroid . In uncontrolled second study phase , comparison thus draw among three therapy group period another 15 month ( altogether 3.5 year begin randomization ) , order throw light medium-term effect steroid-free immunosuppression length growth transplant function .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Age &lt; 18.0 year Bone age boys &lt; 15 year , girl &lt; 13 year Patients 1224 month renal transplantation stable transplant function First second kidney transplant , live cadaver kidney donation Triple immunosuppression cyclosporine ( CyA ) , MMF , daily steroid study entry Patients parent , respectively , give write consent enlightenment ( informed consent ) Irreversible rejection former transplant within 6 month Highly reactive ( &gt; 80 % ) lymphocytotoxic antibody within 12 month prior transplantation Anamnestically steroidresistant rejection current transplant More 2 acute rejection reaction prior study entry ( i.e. , first 1224 month kidney transplantation ) 1 acute rejection reaction last 6 month study entry Glomerular filtration rate ( GFR ) &lt; 40 ml/min/1.73 m² ( Schwartz formula ) study entry Acute rejection reaction unstable transplant function ( increase serum creatinine &gt; 20 % ) last 6 month study entry histologically confirm chronic rejection reaction Suspected insufficient medication compliance Patients receive basic immunosuppression prescribe protocol Simultaneous therapy growth hormone renal transplantation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Pediatric renal transplantation</keyword>
	<keyword>Steroid withdrawal</keyword>
	<keyword>Mycophenolate Mofetil</keyword>
	<keyword>Cyclosporine A</keyword>
	<keyword>Stable graft function</keyword>
	<keyword>child</keyword>
	<keyword>renal transplantation</keyword>
</DOC>